首页> 美国卫生研究院文献>Light Science Applications >In vivo theranostics with near-infrared-emitting carbon dots—highly efficient photothermal therapy based on passive targeting after intravenous administration
【2h】

In vivo theranostics with near-infrared-emitting carbon dots—highly efficient photothermal therapy based on passive targeting after intravenous administration

机译:具有近红外发射碳点的体内治疗疗法-静脉给药后基于被动靶向的高效光热疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Carbon dots that exhibit near-infrared fluorescence (NIR CDs) are considered emerging nanomaterials for advanced biomedical applications with low toxicity and superior photostability and targeting compared to currently used photoluminescence agents. Despite progress in the synthesis of NIR CDs, there remains a key obstacle to using them as an in vivo theranostic agent. This work demonstrates that the newly developed sulfur and nitrogen codoped NIR CDs are highly efficient in photothermal therapy (PTT) in mouse models (conversion efficiency of 59%) and can be readily visualized by photoluminescence and photoacoustic imaging. The real theranostic potential of NIR CDs is enhanced by their unique biodistribution and targeting. Contrary to all other nanomaterials that have been tested in biomedicine, they are excreted through the body’s renal filtration system. Moreover, after intravenous injection, NIR CDs are accumulated in tumor tissue via passive targeting, without any active species such as antibodies. Due to their accumulation in tumor tissue without the need for intratumor injection, high photothermal conversion, excellent optical and photoacoustic imaging performance, and renal excretion, the developed CDs are suitable for transfer to clinical biomedical practice.
机译:与当前使用的光致发光剂相比,具有近红外荧光(NIR CD)的碳点被认为是用于先进生物医学应用的新兴纳米材料,具有低毒性,优异的光稳定性和靶向性。尽管NIR CD的合成取得了进展,但将其用作体内治疗治疗剂仍然存在关键障碍。这项工作表明,新开发的硫和氮共掺杂NIR CD在小鼠模型中对光热疗法(PTT)具有很高的效率(转换效率为59%),并且可以通过光致发光和光声成像轻松看到。 NIR CD的真正治疗潜力通过其独特的生物分布和靶向性得以增强。与已经在生物医学中测试过的所有其他纳米材料相反,它们通过人体的肾脏滤过系统排泄。此外,静脉注射后,NIR CD通过被动靶向在肿瘤组织中积累,而没有任何活性物质(例如抗体)。由于它们在肿瘤组织中的积累,而无需进行肿瘤内注射,高光热转换,出色的光学和光声成像性能以及肾脏排泄,因此开发的CD适合转移到临床生物医学实践中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号